{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:36:57Z","timestamp":1795142217776,"version":"4.10.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell-free DNA (cfDNA) released from damaged or dead cells can activate DNA sensors that exacerbate the pathogenesis of rheumatoid arthritis (RA). Here we show that ~40\u2009nm cationic nanoparticles (cNP) can scavenge cfDNA derived from RA patients and inhibit the activation of primary synovial fluid monocytes and fibroblast-like synoviocytes. Using clinical scoring, micro-CT images, MRI, and histology, we show that intravenous injection of cNP into a CpG-induced mouse model or collagen-induced arthritis rat model can relieve RA symptoms including ankle and tissue swelling, and bone and cartilage damage. This culminates in the manifestation of partial mobility recovery of the treated rats in a rotational cage test. Mechanistic studies on intracellular trafficking and biodistribution of cNP, as well as measurement of cytokine expression in the joints and cfDNA levels in systemic circulation and inflamed joints also correlate with therapeutic outcomes. This work suggests a new direction of nanomedicine in treating inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s41467-018-06603-5","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T12:33:04Z","timestamp":1539174784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation"],"prefix":"10.1038","volume":"9","author":[{"given":"Huiyi","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaji","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-5285","authenticated-orcid":false,"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-9988","authenticated-orcid":false,"given":"Hai-Quan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-4955","authenticated-orcid":false,"given":"Kam W.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2843-5543","authenticated-orcid":false,"given":"Yongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"6603_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023\u20132038 (2016).","journal-title":"Lancet"},{"key":"6603_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. New Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"New Engl. J. Med."},{"key":"6603_CR3","first-page":"1","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh, J. A. et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68, 1\u201326 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"6603_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/annrheumdis-2013-203435","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen, J. S. et al. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study. Ann. Rheum. Dis. 73, 1811\u20131818 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"6603_CR5","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.21382","volume":"52","author":"KL Winthrop","year":"2005","unstructured":"Winthrop, K. L. et al. Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum. 52, 2968\u20132974 (2005).","journal-title":"Arthritis Rheum."},{"key":"6603_CR6","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr, S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659\u20131665 (2001).","journal-title":"Cancer Res."},{"key":"6603_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2165\/11631380-000000000-00000","volume":"42","author":"S Breitbach","year":"2012","unstructured":"Breitbach, S., Tug, S. & Simon, P. Circulating cell-free DNA an up-coming molecular marker in exercise physiology. Sports Med. 42, 565\u2013586 (2012).","journal-title":"Sports Med."},{"key":"6603_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-017-1295-z","volume":"19","author":"E Rykova","year":"2017","unstructured":"Rykova, E. et al. Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers. Arthritis Res. Ther. 19, 10 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"6603_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","volume":"53","author":"XY Zhong","year":"2007","unstructured":"Zhong, X. Y. et al. Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin. Chem. 53, 1609\u20131614 (2007).","journal-title":"Clin. Chem."},{"key":"6603_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1756-185X.12959","volume":"20","author":"T Hashimoto","year":"2017","unstructured":"Hashimoto, T. et al. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis. Int. J. Rheum. Dis. 20, 722\u2013730 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"6603_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-immunol-051116-052331","volume":"35","author":"JT Crowl","year":"2017","unstructured":"Crowl, J. T. et al. Intracellular nucleic acid detection in autoimmunity. Annu. Rev. Immunol. 35, 313\u2013336 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"6603_CR12","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute, V. et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205, 3007\u20133018 (2008).","journal-title":"J. Exp. Med."},{"key":"6603_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564\u2013U566 (2007).","journal-title":"Nature"},{"key":"6603_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","volume":"8","author":"J Tian","year":"2007","unstructured":"Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487\u2013496 (2007).","journal-title":"Nat. Immunol."},{"key":"6603_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).","journal-title":"Nature"},{"key":"6603_CR16","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4049\/jimmunol.165.3.1626","volume":"165","author":"IR Rifkin","year":"2000","unstructured":"Rifkin, I. R. et al. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J. Immunol. 165, 1626\u20131633 (2000).","journal-title":"J. Immunol."},{"key":"6603_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nature05245","volume":"443","author":"K Kawane","year":"2006","unstructured":"Kawane, K. et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443, 998\u20131002 (2006).","journal-title":"Nature"},{"key":"6603_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cytogfr.2008.04.009","volume":"19","author":"S Nagata","year":"2008","unstructured":"Nagata, S. Rheumatoid polyarthritis caused by a defect in DNA degradation. Cytokine Growth F. R. 19, 295\u2013302 (2008).","journal-title":"Cytokine Growth F. R."},{"key":"6603_CR19","doi-asserted-by":"publisher","first-page":"14055","DOI":"10.1073\/pnas.1105777108","volume":"108","author":"J Lee","year":"2011","unstructured":"Lee, J. et al. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl Acad. Sci. USA 108, 14055\u201314060 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6603_CR20","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1073\/pnas.1607011113","volume":"113","author":"EK Holl","year":"2016","unstructured":"Holl, E. K. et al. Scavenging nucleic acid debris to combat autoimmunity and infectious disease. Proc. Natl Acad. Sci. USA 113, 9728\u20139733 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6603_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2017.06.013","volume":"261","author":"M Durymanov","year":"2017","unstructured":"Durymanov, M., Kamaletdinova, T., Lehmann, S. E. & Reineke, J. Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications. J. Control Release 261, 10\u201322 (2017).","journal-title":"J. Control Release"},{"key":"6603_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2017.02.032","volume":"252","author":"MD Yang","year":"2017","unstructured":"Yang, M. D. et al. Nanotherapeutics relieve rheumatoid arthritis. J. Control Release 252, 108\u2013124 (2017).","journal-title":"J. Control Release"},{"key":"6603_CR23","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.200939578","volume":"39","author":"DL Asquith","year":"2009","unstructured":"Asquith, D. L., Miller, A. M., McInnes, I. B. & Liew, F. Y. Animal models of rheumatoid arthritis. Eur. J. Immunol. 39, 2040\u20132044 (2009).","journal-title":"Eur. J. Immunol."},{"key":"6603_CR24","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1021\/bi00635a022","volume":"16","author":"J Olmsted 3rd","year":"1977","unstructured":"Olmsted, J. 3rd & Kearns, D. R. Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids. Biochemistry 16, 3647\u20133654 (1977).","journal-title":"Biochemistry"},{"key":"6603_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"6603_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/9554","volume":"5","author":"GM Deng","year":"1999","unstructured":"Deng, G. M. et al. Intra-articularly localized bacterial DNA containing CpG motifs induced arthritis. Nat. Med. 5, 702\u2013705 (1999).","journal-title":"Nat. Med."},{"key":"6603_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/nn301215q","volume":"7","author":"SM Lee","year":"2013","unstructured":"Lee, S. M. et al. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. ACS Nano 7, 50\u201357 (2013).","journal-title":"ACS Nano"},{"key":"6603_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.1990","volume":"15","author":"S Oney","year":"2009","unstructured":"Oney, S. et al. Development of universal antidotes to control aptamer activity. Nat. Med. 15, 1224\u20131228 (2009).","journal-title":"Nat. Med."},{"key":"6603_CR29","doi-asserted-by":"publisher","first-page":"12938","DOI":"10.1073\/pnas.1204928109","volume":"109","author":"S Jain","year":"2012","unstructured":"Jain, S. et al. Nucleic acid scavengers inhibit thrombosis without increasing bleeding. Proc. Natl Acad. Sci. USA 109, 12938\u201312943 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6603_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1371\/journal.pone.0040862","volume":"7","author":"NA Stearns","year":"2012","unstructured":"Stearns, N. A. et al. The inhibition of anti-DNA binding to DNA by nucleic acid binding polymers. PLoS ONE 7, 7 (2012).","journal-title":"PLoS ONE"},{"key":"6603_CR31","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1021\/acs.biomac.6b01236","volume":"17","author":"JG Jackman","year":"2016","unstructured":"Jackman, J. G. et al. Polycationic nanofibers for nucleic acid scavenging. Biomacromolecules 17, 3706\u20133713 (2016).","journal-title":"Biomacromolecules"},{"key":"6603_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2016.12.024","volume":"120","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials 120, 94\u2013102 (2017).","journal-title":"Biomaterials"},{"key":"6603_CR33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1021\/bm9000298","volume":"10","author":"AS Chauhan","year":"2009","unstructured":"Chauhan, A. S. et al. Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules 10, 1195\u20131202 (2009).","journal-title":"Biomacromolecules"},{"key":"6603_CR34","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1582-4934.2009.00806.x","volume":"14","author":"L Dong","year":"2010","unstructured":"Dong, L. et al. Anti-arthritis activity of cationic materials. J. Cell. Mol. Med. 14, 2015\u20132024 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"6603_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1126\/scitranslmed.3002212","volume":"3","author":"M Hayder","year":"2011","unstructured":"Hayder, M. et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci. Transl. Med. 3, 11 (2011).","journal-title":"Sci. Transl. Med."},{"key":"6603_CR36","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/eji.200838362","volume":"38","author":"M Bokarewa","year":"2008","unstructured":"Bokarewa, M. et al. Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course. Eur. J. Immunol. 38, 3237\u20133244 (2008).","journal-title":"Eur. J. Immunol."},{"key":"6603_CR37","first-page":"12","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 12 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"6603_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1023\/B:PHAM.0000012164.60867.c6","volume":"21","author":"MH Dufresne","year":"2004","unstructured":"Dufresne, M. H. & Leroux, J. C. Study of the micellization behavior of different order amino block copolymers with heparin. Pharm. Res. 21, 160\u2013169 (2004).","journal-title":"Pharm. Res."},{"key":"6603_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","volume":"19","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat. Med. 19, 322\u2013328 (2013).","journal-title":"Nat. Med."},{"key":"6603_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kev312","volume":"55","author":"YJ Xiao","year":"2016","unstructured":"Xiao, Y. J. et al. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking I kappa B kinase-dependent NF-kappa B activation in rheumatoid fibroblast-like synoviocytes. Rheumatology 55, 173\u2013184 (2016).","journal-title":"Rheumatology"},{"key":"6603_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jinorgbio.2009.03.007","volume":"103","author":"A Tarushi","year":"2009","unstructured":"Tarushi, A., Psomas, G., Raptopoulou, C. P. & Kessissoglou, D. P. Zinc complexes of the antibacterial drug oxolinic acid: structure and DNA-binding properties. J. Inorg. Biochem. 103, 898\u2013905 (2009).","journal-title":"J. Inorg. Biochem."},{"key":"6603_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/art.502","volume":"46","author":"GS Firestein","year":"2002","unstructured":"Firestein, G. S. & Zvaifler, N. J. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum. 46, 298\u2013308 (2002).","journal-title":"Arthritis Rheum."},{"key":"6603_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B. & Firestein, G. S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233\u2013255 (2010).","journal-title":"Immunol. Rev."},{"key":"6603_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI113921","volume":"83","author":"PA Guerne","year":"1989","unstructured":"Guerne, P. A. et al. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J. Clin. Investig. 83, 585\u2013592 (1989).","journal-title":"J. Clin. Investig."},{"key":"6603_CR45","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1529-0131(200002)43:2<356::AID-ANR15>3.0.CO;2-J","volume":"43","author":"GM Deng","year":"2000","unstructured":"Deng, G. M. & Tarkowski, A. The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum. 43, 356\u2013364 (2000).","journal-title":"Arthritis Rheum."},{"key":"6603_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1084\/jem.146.3.857","volume":"146","author":"DE Trentham","year":"1977","unstructured":"Trentham, D. E., Townes, A. S. & Kang, A. H. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146, 857\u2013868 (1977).","journal-title":"J. Exp. Med."},{"key":"6603_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1021\/nn4048205","volume":"8","author":"LD Quan","year":"2014","unstructured":"Quan, L. D. et al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano 8, 458\u2013466 (2014).","journal-title":"ACS Nano"},{"key":"6603_CR48","doi-asserted-by":"publisher","first-page":"10974","DOI":"10.3390\/ijms150610974","volume":"15","author":"HQ Zheng","year":"2014","unstructured":"Zheng, H. Q. et al. Physical exercise promotes recovery of neurological function after ischemic stroke in rats. Int. J. Mol. Sci. 15, 10974\u201310988 (2014).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06603-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06603-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T14:12:12Z","timestamp":1671545532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06603-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6603"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06603-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4291"}}